Chinese scientists have found that 62% of multidrug-resistant tuberculosis (MDR-TB) isolates they tested were also resistant to pyrazinamide (PZA), a key drug in treating MDR-TB, according to a study published yesterday in BMC Infectious Diseases.
Group B Streptococcus (GBS) bacteria cause at least 147,000 stillbirths and infant deaths worldwide each year, but providing effective treatment brings up antibiotic resistance and stewardship issues, according to a supplement to Clinical Infectious Diseases published today.
2016 saw 10.4 million TB cases and 1.7 million deaths, with 490,000 multidrug-resistant cases.
Almost a third of TB cases in India are multidrug-resistant, and rates are climbing in Chinese kids.
The fast, automated assay performs well against gold standard TB tests.
An experimental malaria drug called AQ-13 compared well with an established combination treatment in a non-inferiority trial in Malian men with non-severe malaria, according to a report yesterday in The Lancet Infectious Diseases.
A study today in BMC Infectious Diseases reports that patients with multidrug- and extensively drug-resistant tuberculosis (MDR- and XDR-TB) in China's Hunan province had low rates of treatment success.
The Saudi Arabian Ministry of Health (MOH) identified a new case of MERS-CoV in Jeddah today and said a patient identified earlier this week has died from complications of the virus.
A 44-year-old female expatriate in Jeddah is in stable condition after being diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus). The source of her infection is listed as a secondary household contact.
Funds will help combat resistance, launch a TB surveillance center.
The drugs studied are bedaquiline and delamanid, both drugs of last resort.